Review
Open access
Aug 2026
Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives
Lp(a) may soon shift from a “silent threat” to a precise, actionable target in cardiovascular prevention, according to a review of the current evidence, which highlights gaps in knowledge, and discusses emerging therapeutic strategies.
Michał Miszczak, P. Piwowarczyk, G. Sobieszek et al.
· Biomedicines · 0 citations